You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -1,806.6% | -977.3% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -18.6 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 343.3 | 118.9 |
| Price / Book value | 7.6 |
| Latest | Forecast | |
|---|---|---|
| Revenue | -12.0% | 0.0% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2017-04-30 | 0.50 | -7.41 | -8.95p | -5.8 | 0.0 | n/a | n/a | 0.0% |
| 2018-04-30 | 0.63 | -8.93 | -7.91p | -6.0 | 0.0 | n/a | n/a | 0.0% |
| 2019-04-30 | 0.68 | -10.87 | -6.56p | -11.6 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 0.58 | -9.04 | -6.88p | -9.1 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | 0.76 | -13.74 | -6.52p | -7.3 | 0.0 | n/a | n/a | 0.0% |
| Angle completes patient enrolment for ovarian cancer study Sharecast News | 26 Apr |
|---|---|
| Angle secures first large-scale pharma services contract Sharecast News | 16 Apr |
| Angle completes clinical labs in Guildford and Pennsylvania Sharecast News | 30 Mar |
| Exercise of options and total voting rights | 30-Apr-21 11:23 |
|---|---|
| Preliminary Results | 29-Apr-21 07:00 |
| Ovarian cancer study patient enrolment completed | 26-Apr-21 07:00 |
| Second Price Monitoring Extn | 19-Apr-21 14:06 |
| Price Monitoring Extension | 19-Apr-21 14:01 |